Background: Through the AMI-QUEBEC Study we sought to describe delays to reperfusion
therapy for ST-segment elevation myocardial infarction (STEMI) and to identify factors …

Aims To examine the extent of delay from initial hospital presentation to fibrinolytic therapy
or primary percutaneous coronary intervention (PCI), characteristics associated with …

Objectives: We implemented the Mayo Clinic ST-segment elevation myocardial infarction
(STEMI) protocol and evaluated the timeliness of reperfusion therapy during off hours versus …

Background Early reperfusion therapy in ST-elevation myocardial infarction (STEMI)
correlates with its success. The aim of our study was to characterize patients admitted with a …

Background Recent research and contemporary ST elevation myocardial infarction
guidelines emphasize the importance of prompt reperfusion and have redefined the …

Objective To investigate whether admission time was associated with the delay of
reperfusion therapy and in-hospital death in patients with ST-elevation myocardial infarction …

Background: Time delays to reperfusion therapy in ST-segment elevation myocardial
infarction (STEMI) still remain a considerable drawback in many healthcare systems …

Objectives To evaluate emergency medical services (EMS) delays and their impact on time
to treatment and mortality in patients with ST-elevation myocardial infarction (STEMI) …

Primary percutaneous coronary intervention (PCI) is the preferred reperfusion strategy for ST
elevation myocardial infarction (STEMI). However, only one-third of hospitals in the US have …

Background Treatment delay is an important prognostic factor for patients with acute ST-
elevation myocardial infarction (STEMI) treated with primary percutaneous coronary …